Related Experiment Video
Updated: May 18, 2026

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats
Published on: November 20, 2015
A case of extreme prematurity and delayed diagnosis of pyridoxine-dependent epilepsy
Abdulaziz S Al-Saman1, Tamer M Rizk
1Department of Pediatric Neurology, National Neuroscience Institute, King Fahad Medical City, Riyadh, Kingdom of Saudi Arabia.
Insights
Pyridoxine-dependent epilepsy, a rare condition, requires lifelong vitamin B6 treatment. Early diagnosis and management are crucial, even in premature infants with difficult-to-treat seizures.
Area of Science:
- Neurology
- Genetics
- Biochemistry
Background:
- Pyridoxine-dependent epilepsy (PDE) is a severe genetic disorder presenting in infancy.
- It is characterized by refractory seizures unresponsive to standard antiepileptic drugs.
- Lifelong pyridoxine (vitamin B6) supplementation is the only effective treatment.
Observation:
- A premature infant born at 25 weeks gestation exhibited abnormal movements and refractory status epilepticus.
- Seizures were resistant to multiple antiepileptic medications.
- Intravenous pyridoxine successfully controlled the seizures.
Findings:
- Elevated urinary α-aminoadipic semialdehyde confirmed PDE.
- Genetic analysis revealed a homozygous c.1195G>C mutation in the ALDH7A1 gene.
- The ALDH7A1 gene encodes aldehyde dehydrogenase 7 family member A1.
Implications:
- This case highlights the importance of considering PDE in infants with unexplained, refractory seizures, irrespective of prematurity.
- Early diagnosis and pyridoxine treatment can prevent severe neurological consequences.
- Genetic confirmation of ALDH7A1 mutations solidifies the diagnosis and guides long-term management.
Abstract:
Pyridoxine-dependent epilepsy presents early in life, even in utero. It is usually refractory to conventional antiepileptic medications and responds only to lifelong pyridoxine supplementation. Seizures are usually generalized tonic clonic. We report a 3-year-old child that was born prematurely at 25 weeks of gestation. He presented with abnormal movements in the second month of life. At 10 months of age he presented with status epilepticus, which was refractory to multiple antiepileptic medications and was controlled with intravenous pyridoxine. An elevated level of a-aminoadipic semialdehyde excretion in the urine supported the diagnosis of pyridoxine-dependent epilepsy. Subsequently, a c.1195G>C homozygous mutation in the 5q31 aldehyde dehydrogenase 7A1 gene was confirmed. This case calls for considering pyridoxine-dependent epilepsy and its early management in cases with resistant seizures; even in the presence of extreme prematurity with its neurological consequences.
Related Concept Videos
Inborn Errors of Metabolism
Epilepsy ll: Types
Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Seizures: Classification
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Overview of Protein Metabolism
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
